Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2012
03/15/2012US20120065253 Genetic modification of targeted regions of the cardiac conduction system
03/15/2012US20120065130 Methods for treating congestive heart failure
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064578 Chromosome-based platforms
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064532 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
03/15/2012US20120064038 Epidermal growth factor receptor (egfr) and methods of use in adenoviral-associated virus type 6 (aav6) transduction
03/15/2012CA2810327A1 Use of a dna expression construct
03/14/2012EP2428571A1 MicroRNA molecules
03/14/2012EP2428570A1 MicroRNA molecules
03/14/2012EP2428569A1 MicroRNA molecules
03/14/2012EP2428568A1 MicroRNA molecules
03/14/2012EP2428567A1 MicroRNA molecules
03/14/2012EP2428566A1 Gene transfer agent composition containing polyamidoamine dendron
03/14/2012EP2428229A1 Oncolytic adenoviruses for treating cancer
03/14/2012EP2428228A1 Use of a linear DNA expression construct with covalently closed ends
03/14/2012EP2428227A1 Compositions and their uses directed to Huntingtin
03/14/2012EP2428210A1 Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
03/14/2012EP2427554A2 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
03/14/2012EP2427553A2 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
03/14/2012EP2427472A1 Lipophilic polynucleotide conjugates
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP1804839B1 Improved expression of factor ix in gene therapy vectors
03/14/2012EP1599586B9 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012CN1903870B Single chain DNA having therapeutic action against virus infection disease
03/14/2012CN102373232A Novel tissue specific minicircle vector-hIFNgama gene therapeutic drug
03/14/2012CN102373218A Nucleic acid sequence coding Momordica charantia polypeptide P
03/14/2012CN102373212A Chymotrypsin nucleic acid aptamers, preparation method and application thereof
03/14/2012CN102373211A Set of trypsin nucleic acid aptamers, preparation method thereof, and application thereof
03/14/2012CN102373210A MicroRNA (Ribonucleic Acid) relevant to diabetes mellitus endothelial progenitor cell paralysis and application thereof
03/14/2012CN102373206A PPP2R5C-siRNA799 for targeted inhabitation of PPP2R5C gene expression and tumor T cell multiplication and application thereof
03/14/2012CN102370988A Technology for transferring antitumor medicament with single-wall carbon nanotube and application thereof
03/14/2012CN102370987A Injection liposome entrapping antineoplastic pharmaceutical composition
03/14/2012CN102370977A Novel vaccine adjuvant and application
03/14/2012CN101565455B CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
03/14/2012CN101450216B Medicine for preventing hyperplastic scar fibroblast proliferation
03/14/2012CN101148467B Oligonucleotide and use thereof for treating lung cancer
03/13/2012US8133903 Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
03/13/2012US8133878 Methods for treating restenosis
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133876 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
03/13/2012US8133873 Recombinant chemokine-antigen vaccine
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012US8133494 Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
03/13/2012US8133481 Selectively replicating viral vectors
03/13/2012CA2660842C Polyconjugates for in vivo delivery of polynucleotides
03/13/2012CA2567254C Tc-83-derived alphavirus vectors, particles and methods
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2208524C Delivery of nucleic acid molecules to mucosal tissue
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/13/2012CA2191220C Cdna for human methylenetetrahydrofolate reductase
03/08/2012WO2012031137A2 Vesicular stomatitis viruses
03/08/2012WO2012030901A1 Small liposomes for delivery of immunogen-encoding rna
03/08/2012WO2012030626A2 Design of oligonucleotide analogs as therapeutic agents
03/08/2012WO2012029958A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2011159758A4 Long lasting drug formulations
03/08/2012WO2011146675A3 Treatment of lim homeobox 2 (lhx2) related diseases by inhibition of natural antisense transcript to lhx2
03/08/2012WO2011118994A9 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120059047 Differentiation modulating agents and uses therefor
03/08/2012US20120058538 Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
03/08/2012US20120058487 Compositions and methods for detecting klebsiella pneumoniae
03/08/2012US20120058188 Lipid encapsulated interfering rna
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058139 Novel multimodular assembly useful for intracellular delivery
03/08/2012US20120058108 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
03/08/2012US20120058092 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
03/08/2012US20120058091 Diagnostic and therapeutic treatments related to mitochondrial disorders
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058086 Compositions, kits, and methods for promoting ischemic and diabetic wound healing
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012CA2847413A1 Vesicular stomatitis viruses
03/08/2012CA2809678A1 Small liposomes for delivery of immunogen-encoding rna
03/07/2012EP2426142A2 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
03/07/2012EP2425256A1 Method for diagnosing and treating muscular dystrophy
03/07/2012EP2424987A2 Antisense oligonucleotides of hemoglobins
03/07/2012EP2424979A1 Method for production of anti-tumor trail protein
03/07/2012EP2424978A1 Compositions and methods for modulating stem cells and uses thereof
03/07/2012EP2424572A1 Targeting nucleic acids in the mitochondria
03/07/2012EP2424571A2 Gene vector
03/07/2012EP1474522B1 A method for generating engineered cells for locus specific gene regulation and analysis
03/07/2012EP1446412B1 Novel lna compositions and uses thereof
03/07/2012CN102369283A Rnai molecule for thymidylate synthase and use thereof
03/07/2012CN102369282A Nucleic acid complex and nucleic acid-delivering composition
03/07/2012CN102369024A Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
03/07/2012CN102366631A Application of recombinant adeno-associated virus (AAV) expressing BDNF-HA2TAT in preparing medicaments treating depression diseases
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012US8129353 Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter
03/06/2012US8129352 Antisense antiviral compound and method for treating ssRNA viral infection
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129144 Papilloma pseudovirus and preparation
03/06/2012US8128935 DNA sequence and recombinant production of the grass pollen allergen Phl p 4
03/06/2012US8128931 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 870